Search Results - "Tideman, P."

Epilepsy surgery in children with drug-resistant epilepsy, a long-term follow-up by Hallböök, T., Tideman, P., Rosén, I., Lundgren, J., Tideman, E.

“…Objectives In this follow‐up study, we wanted to present the long‐term outcome (5–21 years) in terms of seizure freedom, seizure reduction, and the cognitive…”
Get full text

Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol by König, Alexandra, Linz, N., Baykara, E., Tröger, J., Ritchie, C., Saunders, S., Teipel, S., Köhler, S., Sánchez-Benavides, G., Grau-Rivera, O., Gispert, J. D., Palmqvist, S., Tideman, P., Hansson, O.

“…Background Speech impairments are an early feature of Alzheimer’s disease (AD) and consequently, analysing speech performance is a promising new digital…”
Get full text

Does Tenecteplase Use Comply With Evidence Base? by Tideman, P, Tirimacco, R, Simpson, P, Cowley, P, Siew, L

Get full text

Subspecialisation in cardiology care and outcome: should clinical services be redesigned, again? by Pathik, B., De Pasquale, C. G., McGavigan, A. D., Sinhal, A., Vaile, J., Tideman, P. A., Jones, D., Bridgman, C., Selvanayagam, J. B., Heddle, W., Chew, D. P.

“…Background Inpatient management of cardiac patients by cardiologists results in reduced mortality and hospitalisation. With increasing subspecialisation of the…”
Get full text

Delta change analysis of troponin T for the diagnosis of AMI by Tideman, P, Tirimacco, R, Simpson, P, Cowley, P, Siew, L, Berry, N

Get full text

Country access to cardiac health (CATCH) program: improving rehospitalisation rates and length of stay for cardiac rehabilitation using innovative telehealth delivery by Tideman, P, Tirimacco, R, Berry, N, Cowley, P, Jones, S, Church, A, Clark, R

Get full text

PoCT troponin - is it safe? by Tideman, P, Tirimacco, R, Simpson, P, Cowley, P, Siew, M, Berry, N

Get full text

The association between condition-specific streaming and outcomes in modern cardiovascular care by O'Shea, C, Chew, D, Balakrishnan, D, Horsfall, M, McGavigan, A, De Pasquale, C, Tideman, P, Aylward, P, Moyes, B

Get full text

Development of an Integrated, Digitally-Based & State-Wide Cardiac Clinical Management Network by Tideman, P, Tirimacco, R, Simpson, P, Cowley, P, Siew, M

Get full text

Subspecialisation in cardiology care and outcome: Should clinical services be redesigned, again? by Pathik, B, De Pasquale, C, McGavigan, A, Sinhal, A, Vaile, J, Tideman, P, Jones, D, Bridgman, C, Selvanayagam, J, Heddle, W, Chew, D

Get full text

Virtual Support of a Point of Care Testing Network by Tirimacco, R, Cowley, P, St John, A, Siew, L, Tideman, P

Get full text

Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle Risk Factor Study 2004-2006 by Janus, E. D., Bunker, S. J., Kilkkinen, A., Namara, K. Mc, Philpot, B., Tideman, P., Tirimacco, R., Laatikainen, T. K., Heistaro, S., Dunbar, J. A.

“…Background:  Hypertension is an important risk factor for cardiovascular disease; however, limited findings are available on its detection and management in…”
Get full text

Cardiac Clinical Network, Reducing Total Length of Stay for AMI Patients by Tideman, P, Tirimacco, R, Simpson, P

Get full text

Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures by Palmqvist, Sebastian, Tideman, Pontus, Cullen, Nicholas, Zetterberg, Henrik, Blennow, Kaj, Dage, Jeffery L., Stomrud, Erik, Janelidze, Shorena, Mattsson-Carlgren, Niklas, Hansson, Oskar

“…A combination of plasma phospho-tau (P-tau) and other accessible biomarkers might provide accurate prediction about the risk of developing Alzheimer’s disease…”
Get full text

2011 Addendum to the Guidelines for the Management of Acute Coronary Syndromes 2006 by Chew, D, Aroney, C, Aylward, P, White, H, Tideman, P, Kelly, A, Waddell, J, Azadi, L, Wilson, A, Ruta, L

Get full text

Increased troponin T in a patient with dermatomyositis by White, G H, Tideman, P A

Get full text

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers by Mattsson-Carlgren, Niklas, Salvadó, Gemma, Ashton, Nicholas J, Tideman, Pontus, Stomrud, Erik, Zetterberg, Henrik, Ossenkoppele, Rik, Betthauser, Tobey J, Cody, Karly Alex, Jonaitis, Erin M, Langhough, Rebecca, Palmqvist, Sebastian, Blennow, Kaj, Janelidze, Shorena, Johnson, Sterling C, Hansson, Oskar

“…Alzheimer disease (AD) pathology starts with a prolonged phase of β-amyloid (Aβ) accumulation without symptoms. The duration of this phase differs greatly…”
Get more information

Testing an Innovative Model for Secondary Prevention and Cardiac Rehabilitation: The Electronic Outpatient Cardiac Rehabilitation Program (eOCR) Proof of Concept Testing in the South East and Riverland Regions of South Australia by Tideman, P, Mummery, K, Tirimacco, R, Vandelanotte, C, Poulsen, V, Simpson, P, Clark, R, Duncan, M, Van Itallie, A, Corry, K

Get full text

Cognitive effects of Lewy body pathology in clinically unimpaired individuals by Palmqvist, Sebastian, Rossi, Marcello, Hall, Sara, Quadalti, Corinne, Mattsson-Carlgren, Niklas, Dellavalle, Sofia, Tideman, Pontus, Pereira, Joana B., Nilsson, Maria H., Mammana, Angela, Janelidze, Shorena, Baiardi, Simone, Stomrud, Erik, Parchi, Piero, Hansson, Oskar

“…α-Synuclein aggregates constitute the pathology of Lewy body (LB) disease. Little is known about the effects of LB pathology in preclinical (presymptomatic)…”
Get full text

An Innovative Business Model Using Established Medicare Items for Delivery of Cardiac Rehabilitation—A Value Proposition for Primary Care by Bulamu, N., Beleigoli, A., Wanguhu, K., Haydon, D., Gebremichael, L., Powell, S., Tideman, P., Kaambwa, B., Clark, R.

Get full text